Literature DB >> 15755460

Epidemiology and risk factors for chronic kidney disease.

William M McClellan1.   

Abstract

Kidney disease is highly prevalent in the United States population and groups at high risk for increased prevalence of CKD include individuals with a family history of ESRD, diabetes, hypertension, and cardiovascular disease. Despite the increased risk of ESRD observed for blacks compared with whites, racial disparities in the prevalence of kidney disease have not been consistently demonstrated in the United States population. Although the reasons for discrepancy in risk of ESRD and CKD have not been established, clinicians should be aware that more rapid progression of CKD among blacks is a possible explanation for this observation and that closer monitoring and intensive care of risk factors associated with progressive renal injury is warranted for blacks with CKD and in other high-risk groups. Therapeutic interventions that delay or prevent progressive kidney disease are well established and incorporated into widely disseminated clinical practice guidelines. These interventions include aggressive blood pressure control with agents that block the renin-angiotensin system, reduction of dietary protein to recommended levels for the American diet, weight loss, smoking cessation, and control of hyperlipidemia. These interventions also reduce the risk of cardiovascular disease and should be regarded as essential components of care of CKD. Achieving high levels of medically appropriate care of CKD patients and reduction in risk of progression to ESRD may be delayed by barriers created by individual and regional poverty.

Entities:  

Mesh:

Year:  2005        PMID: 15755460     DOI: 10.1016/j.mcna.2004.11.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  27 in total

1.  Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRD.

Authors:  William M McClellan; David G Warnock; Suzanne Judd; Paul Muntner; Rachel E Patzer; Brian D Bradbury; Leslie A McClure; Britt B Newsome; George Howard
Journal:  Am J Kidney Dis       Date:  2011-11-10       Impact factor: 8.860

2.  Nicaragua revisited: evidence of lower prevalence of chronic kidney disease in a high-altitude, coffee-growing village.

Authors:  Timothy S Laux; Philip J Bert; Gerardo M Barreto Ruiz; Marvin González; Mark Unruh; Aurora Aragon; Cecilia Torres Lacourt
Journal:  J Nephrol       Date:  2012 Jul-Aug       Impact factor: 3.902

3.  Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94).

Authors:  Michelle M Estrella; Brad C Astor; Anna Köttgen; Elizabeth Selvin; Josef Coresh; Rulan S Parekh
Journal:  Nephrol Dial Transplant       Date:  2010-02-22       Impact factor: 5.992

4.  The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease.

Authors:  Susan L Furth; Stephen R Cole; Jeffrey J Fadrowski; Arlene Gerson; Christopher B Pierce; Manju Chandra; Robert Weiss; Frederick Kaskel
Journal:  Pediatr Nephrol       Date:  2006-11-21       Impact factor: 3.714

5.  Influence of education and neighborhood poverty on pressor responses to phenylephrine in African-Americans and Caucasian-Americans.

Authors:  KaMala S Thomas; Richard A Nelesen; Michael G Ziegler; Loki Natarajan; Joel E Dimsdale
Journal:  Biol Psychol       Date:  2009-05-07       Impact factor: 3.251

6.  Chronic kidney disease after autologous stem cell transplantation: analysis of a single center experience.

Authors:  QiaoYuan Wu; XiaoHong Li; YongRong Lai; ZhiGang Peng; YunHua Liao
Journal:  Int Urol Nephrol       Date:  2014-03-26       Impact factor: 2.370

7.  Race and sex differences in rates of diabetic complications.

Authors:  Yun Shen; Lizheng Shi; Elizabeth Nauman; Peter T Katzmarzyk; Eboni G Price-Haywood; Ping Yin; Alessandra N Bazzano; Somesh Nigam; Gang Hu
Journal:  J Diabetes       Date:  2018-11-13       Impact factor: 4.006

Review 8.  Depression and mortality in end-stage renal disease.

Authors:  Nisha Ver Halen; Daniel Cukor; Melissa Constantiner; Paul L Kimmel
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

Review 9.  Diabetes, anemia and CKD: Why TREAT?

Authors:  Ajay K Singh
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

10.  Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation.

Authors:  Michael Choi; Can-Lan Sun; Seira Kurian; Andrea Carter; Liton Francisco; Stephen J Forman; Smita Bhatia
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.